We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KGC icon
351
Kinross Gold
KGC
$27B
$2.09M 0.02%
68,516
-35,300
-34% -$1.16M
FWONK icon
352
Liberty Media Series C
FWONK
$25.6B
$2.09M 0.02%
24,528
+434
+2% +$37.9K
ZBH icon
353
Zimmer Biomet
ZBH
$17.6B
$2.08M 0.02%
23,040
+379
+2% +$34.8K
GEHC icon
354
GE HealthCare
GEHC
$28.7B
$2.08M 0.02%
29,171
+444
+2% +$35K
SJM icon
355
J.M. Smucker
SJM
$12B
$2.04M 0.02%
21,105
+543
+3% +$56.9K
VEEV icon
356
Veeva Systems
VEEV
$31.7B
$2.03M 0.02%
11,576
+405
+4% +$79.6K
BE icon
357
Bloom Energy
BE
$61.1B
$2.03M 0.02%
15,008
+1,957
+15% +$287K
GEN icon
358
Gen Digital
GEN
$16.1B
$2.02M 0.02%
107,277
+1,924
+2% +$44.5K
FOXA icon
359
Fox Class A
FOXA
$24.2B
$1.96M 0.02%
33,553
+572
+2% +$36.5K
TSN icon
360
Tyson Foods
TSN
$20.3B
$1.9M 0.02%
29,687
+791
+3% +$49.1K
TRMB icon
361
Trimble
TRMB
$12.3B
$1.9M 0.02%
29,155
+454
+2% +$31.6K
CHTR icon
362
Charter Communications
CHTR
$16.2B
$1.89M 0.02%
8,775
+155
+2% +$33.6K
MFC icon
363
Manulife Financial
MFC
$72.1B
$1.87M 0.02%
54,570
– –
BXP icon
364
Boston Properties
BXP
$11.1B
$1.87M 0.02%
36,029
+839
+2% +$50.5K
REG icon
365
Regency Centers
REG
$15.1B
$1.87M 0.02%
24,688
+320
+1% +$23.8K
WSM icon
366
Williams-Sonoma
WSM
$26.9B
$1.86M 0.02%
10,200
+158
+2% +$31.5K
ZS icon
367
Zscaler
ZS
$24.2B
$1.85M 0.02%
13,193
+211
+2% +$37.4K
IQV icon
368
IQVIA
IQV
$34.4B
$1.84M 0.02%
10,767
+149
+1% +$29.1K
PNR icon
369
Pentair
PNR
$10.1B
$1.82M 0.02%
20,917
+129
+0.6% +$12.6K
RIVN icon
370
Rivian
RIVN
$25.3B
$1.8M 0.02%
119,654
+2,280
+2% +$36.4K
NI icon
371
NiSource
NI
$22B
$1.79M 0.02%
38,260
+1,628
+4% +$73.3K
CLX icon
372
Clorox
CLX
$11.6B
$1.76M 0.02%
17,030
+294
+2% +$33.3K
CLS icon
373
Celestica
CLS
$34.6B
$1.76M 0.02%
6,243
– –
TRU icon
374
TransUnion
TRU
$15.4B
$1.73M 0.02%
24,938
+415
+2% +$31.8K
BN icon
375
Brookfield
BN
$107B
$1.69M 0.02%
41,776
-900
-2% -$39.9K
13 14
15
16 17

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.